Trial NCT00281879

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000452794
Secondary IDs: OHSU-540 OHSU-TPI-9695-L P30CA016058

Last trial update was posted on 2017-09-27

MeSH Interventions

Antilymphocyte Serum Busulfan Carmustine Cyclophosphamide Cyclosporine Cyclosporins Cytarabine Etoposide Fludarabine Fludarabine phosphate Melphalan Methotrexate Methylprednisolone Mycophenolic Acid Tacrolimus

MeSH Conditions

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Neoplasms Neoplasms, Plasma Cell Plasmacytoma Preleukemia Syndrome

Other Conditions

Chronic Myeloproliferative Disorders Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood

Stopping Reasons

N/A

Limitations And Caveats

Early termination

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID